Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Apogee Therapeutics Inc (APGE)

Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Apogee Therapeutics Inc 221 CRESCENT ST. BUILDING 17 SUITE 102B WALTHAM MA 02453 USA

www.apogeetherapeutics.com Employees: 91 P: 650-394-5230

Description:

Apogee Therapeutics LLC is a biotechnology company advancing novel, potentially therapies to address the needs of the millions of people living with immunological and inflammatory disorders. Apogee Therapeutics LLC is based in SAN FRANCISCO.

Key Statistics

Overview:

Market Capitalization, $K 2,028,016
Enterprise Value, $K 1,909,696
Shares Outstanding, K 45,027
Annual Sales, $ 0 K
Annual Net Income, $ -83,990 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -49,020 K
EBIT, $ -178,150 K
EBITDA, $ -181,220 K
60-Month Beta 2.93
% of Insider Shareholders 36.10%
% of Institutional Shareholders 79.04%
Float, K 28,772
% Float 63.90%
Short Volume Ratio 0.62

Growth:

1-Year Return 144.08%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.86 on 11/12/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -2.42
EPS Growth vs. Prev Qtr -43.33%
EPS Growth vs. Prev Year -68.63%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

APGE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -21.81%
Return-on-Assets % -20.94%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.85
Book Value/Share 16.32
Interest Coverage -2.42
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar